Table: Cosmos Pharmaceutical -2015/16 group results

Cosmos Pharmaceutical

11/07/2016 07:30

Jul 11 (Reuters)-  
          Cosmos Pharmaceutical Corp.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              May 31, 2016    May 31, 2015   May 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales          447.27          408.47         490.00        240.00    
               (+9.5 pct)      (+9.9 pct)     (+9.6 pct)   (+10.8 pct)  
  Operating       18.65           17.08          18.70          9.55    
               (+9.2 pct)      (+2.2 pct)     (+0.3 pct)    (+4.4 pct)  
  Recurring       20.69           19.03          20.70         10.55    
               (+8.7 pct)      (+4.6 pct)     (+0.0 pct)    (+3.7 pct)  
  Net 
  Net             12.44           11.69          13.50          6.90    
               (+6.3 pct)      (+10.3 pct)    (+8.6 pct)   (+12.4 pct)  
  EPS          628.05 yen      590.63 yen     681.83 yen    348.49 yen  
  Ann Div       65.00 yen       60.00 yen      70.00 yen                
  -Q2 Div       30.00 yen       27.50 yen      35.00 yen                
  -Q4 Div       35.00 yen       32.50 yen      35.00 yen                
   
  NOTE - Cosmos Pharmaceutical Corp.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T 
  ((Tokyo Headline News Desk +813 6441 1812))